Announcement on Voluntary Disclosure of Triggering of Milestone Payment Conditions by Wholly-owned Subsidiary Systimmune and Bristol-Myers Squibb for the Global Strategic Cooperation Agreement of iza-bren

About this update from Sichuan Biokin Pharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure of Triggering of Milestone Payment Conditions by Wholly-owned Subsidiary Systimmune and Bristol-Myers Squibb for the Global Strategic Cooperation Agreement of iza-brenThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sichuan Biokin Pharmaceutical Co., Ltd. Class A